Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With (99m)Tc-Labeled Duramycin SPECT/CT

Our goal was to validate the feasibility of (99m)Tc-duramycin as a potential apoptosis probe for monitoring tumor response to paclitaxel in breast cancer xenografts. The binding of (99m)Tc-duramycin to phosphatidylethanolamine was validated in vitro using paclitaxel-treated human breast carcinoma MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rui, Niu, Lei, Qiu, Fan, Fang, Wei, Fu, Tong, Zhao, Ming, Zhang, Ying-Jian, Hua, Zi-Chun, Li, Xiao-Feng, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469599/
https://www.ncbi.nlm.nih.gov/pubmed/27030401
http://dx.doi.org/10.1177/1536012115624918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469599/
https://www.ncbi.nlm.nih.gov/pubmed/27030401
http://dx.doi.org/10.1177/1536012115624918

Ejemplares similares